Caffeic acid phenethyl ester inhibits epithelial-mesenchymal transition of human pancreatic cancer cells

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Chen, Ming Jen ^a,b   Shih, Shou Chuan ^a,b   Wang, Horng Yuan ^a,b   Lin, Ching Chung ^a,b   Liu, Chia Yuan ^a,b   Wang, Tsang En ^a,b   Chu, Cheng Hsin ^a,b   Chen, Yu Jen ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; GEMCITABINE; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; WESTERN BLOTTING;

EID: 84877304728     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/270906     Document Type: Article

References (31)

1. Jemal A., Siegel R., Xu J., Ward E., Cancer statistics. CA: A Cancer Journal for Clinicians 2010 60 277 300
2. Yeo T. P., Hruban R. H., Leach S. D., Wilentz R. E., Sohn T. A., Kern S. E., Iacobuzio-Donahue C. A., Maitra A., Goggins M., Canto M. I., Abrams R. A., Laheru D., Jaffee E. M., Hidalgo M., Yeo C. J., Pancreatic cancer. Current Problems in Cancer 2002 26 4 176 275 2-s2.0-19044364689
3. Abbruzzese J. L., New applications of gemcitabine and future directions in the management of pancreatic cancer. Cancer 2002 95 941 945 (Pubitemid 34839690)
4. Kindler H. L., Front-line therapy of advanced pancreatic cancer. Seminars in Oncology 2005 32 S33 S36 (Pubitemid 43080912)
5. Lockhart A. C., Rothenberg M. L., Berlin J. D., Treatment for pancreatic cancer: current therapy and continued progress. Gastroenterology 2005 128 1642 1654 (Pubitemid 40692557)
6. Acloque H., Adams M. S., Fishwick K., Bronner-Fraser M., Nieto M. A., Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. Journal of Clinical Investigation 2009 119 6 1438 1449 2-s2.0-67650996280 10.1172/JCI38019
7. Arumugam T., Ramachandran V., Fournier K. F., Wang H., Marquis L., Abbruzzese J. L., Gallick G. E., Logsdon C. D., McConkey D. J., Choi W., Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Research 2009 69 14 5820 5828 2-s2.0-67650999217 10.1158/0008-5472.CAN-08-2819
8. Moreno-Bueno G., Portillo F., Cano A., Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008 27 6958 6969
9. Wang H., Wu J., Zhang Y., Transforming growth factor β -induced epithelial-mesenchymal transition increases cancer stem-like cells in the PANC-1 cell line. Oncology Letters 2012 3 229 233
10. Fensterer H., Giehl K., Buchholz M., Ellenrieder V., Buck A., Kestler H. A., Adler G., Gierschik P., Gress T. M., Expression profiling of the influence of RAS mutants on the TGFB1-induced phenotype of the pancreatic cancer cell line PANC-1. Genes Chromosomes and Cancer 2004 39 3 224 235 2-s2.0-1142286408 10.1002/gcc.20000 (Pubitemid 38209583)
11. Singh A., Settleman J., EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010 29 34 4741 4751 2-s2.0-77956178360 10.1038/onc.2010.215
12. Du Z., Qin R., Wei C., Wang M., Shi R C., Tian, Peng C., Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells. Digestive Diseases and Sciences 2011 56 741 750
13. Cates J. M. M., Byrd R. H., Fohn L. E., Tatsas A. D., Washington M. K., Black C. C., Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma. Pancreas 2009 38 1 e1 e6 2-s2.0-59649090098 10.1097/MPA. 0b013e3181878b7f
14. De Wever O., Pauwels P., De Craene B., Sabbah M., Emami S., Redeuilh G., Gespach C., Bracke M., Berx G., Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochemistry and Cell Biology 2008 130 3 481 494 2-s2.0-50249141697 10.1007/s00418-008-0464-1
15. Vincent T., Neve E. P. A., Johnson J. R., Kukalev A., Rojo F., Albanell J., Pietras K., Virtanen I., Philipson L., Leopold P. L., Crystal R. G., de Herreros A. G., Moustakas A., Pettersson R. F., Fuxe J., A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF- β mediated epithelial-mesenchymal transition. Nature Cell Biology 2009 11 8 943 950 2-s2.0-68249092353 10.1038/ncb1905
16. Olmeda D., Moreno-Bueno G., Flores J. M., Fabra A., Portillo F., Cano A., SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells. Cancer Research 2007 67 24 11721 11731 2-s2.0-37549006304 10.1158/0008-5472.CAN-07-2318
17. Sun T., Zhao N., Zhao X. L., Gu Q., Zhang S. W., Che N., Wang X. H., Du J., Liu Y. X., Sun B. C., Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology 2010 51 2 545 556 2-s2.0-75449104452 10.1002/hep.23311
18. Lenferink A. E. G., Cantin C., Nantel A., Wang E., Durocher Y., Banville M., Paul-Roc B., Marcil A., Wilson M. R., O'Connor-Mccourt M. D., Transcriptome profiling of a TGF- Β -induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies. Oncogene 2010 29 6 831 844 2-s2.0-76849101945 10.1038/onc.2009.399
19. Sabbah M., Emami S., Redeuilh G., Julien S., Prévost G., Zimber A., Ouelaa R., Bracke M., De Wever O., Gespach C., Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resistance Updates 2008 11 4-5 123 151 2-s2.0-53249130662 10.1016/j.drup.2008.07.001
20. Son S., Lewis B. A., Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure-activity relationship. Journal of Agricultural and Food Chemistry 2002 50 3 468 472 2-s2.0-0037196121 10.1021/jf010830b (Pubitemid 34106663)
21. Ozyurt H., Irmak M. K., Akyol O., Sogut S., Caffeic acid phenethyl ester changes the indices of oxidative stress in serum of rats with renal ischaemia-reperfusion injury. Cell Biochemistry and Function 2001 19 259 263 (Pubitemid 33097881)
22. Michaluart P., Masferrer J. L., Carothers A. M., Subbaramaiah K., Zweifel B. S., Koboldt C., Mestre J. R., Grunberger D., Sacks P. G., Tanabe T., Dannenberg A. J., Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Research 1999 59 10 2347 2352 2-s2.0-0033562995 (Pubitemid 29242281)
23. Natarajan K., Singh S., Burke T. R., Grunberger D., Aggarwal B. B., Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proceedings of the National Academy of Sciences of USA 1996 93 9090 9095 (Pubitemid 26282023)
24. Chen Y. J., Shiao M. S., Wang S. Y., The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells. Anti-Cancer Drugs 2001 12 2 143 149 2-s2.0-0035097459 10.1097/00001813-200102000-00008 (Pubitemid 32207364)
25. Watabe M., Hishikawa K., Takayanagi A., Shimizu N., Nakaki T., Caffeic acid phenethyl ester induces apoptosis by inhibition of NF B and activation of fas in human breast cancer MCF-7 cells. Journal of Biological Chemistry 2004 279 7 6017 6026 2-s2.0-1242294398 10.1074/jbc.M306040200 (Pubitemid 38220634)
26. Liao H. F., Chen Y. Y., Liu J. J., Hsu M. L., Shieh H. J., Liao H. J., Shieh C. J., Shiao M. S., Chen Y. J., Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. Journal of Agricultural and Food Chemistry 2003 51 27 7907 7912 2-s2.0-0346336175 10.1021/jf034729d
27. Morel A. P., Lièvre M., Thomas C., Hinkal G., Ansieau S., Puisieux A., Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008 3 8, article e2888 2-s2.0-51449085561 10.1371/journal.pone.0002888
28. Vincent T., Neve E. P. A., Johnson J. R., Kukalev A., Rojo F., Albanell J., Pietras K., Virtanen I., Philipson L., Leopold P. L., Crystal R. G., de Herreros A. G., Moustakas A., Pettersson R. F., Fuxe J., A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF- β mediated epithelial-mesenchymal transition. Nature Cell Biology 2009 11 8 943 950 2-s2.0-68249092353 10.1038/ncb1905
29. Sarkar H., Li Y., Wang Z., Kong D., Pancreatic cancer stem cells and EMT in drug resistance and metastasis. Minerva Chirurgica 2009 64 489 500
30. Lee Y. J., Liao P. H., Chen W. K., Yang C. Y., Preferential cytotoxicity of caffeic acid phenethyl ester analogues on oral cancer cells. Cancer Letters 2000 153 51 56
31. Fuxe J., Vincent T., De Herreros A. G., Transcriptional crosstalk between TGF β and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 2010 9 12 2363 2374 2-s2.0-77954167982 10.4161/cc.9.12.12050